Email this article Press-reliz Na XIII Rossiyskom kongresse onkologov obsudili sostoyanie epidemiologicheskoy programmy skrininga HER2-statusa u zhenshchin, bol'nykh rakom molochnoy zhelezy (RMZh), a takzhe preimushchestvai perspektivy targetnoy terapii preparatami Gertseptin i Avastin
- Authors: - -
- Issue: Vol 11, No 4 (2009)
- Pages: 27-28
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/26797
- ID: 26797
Cite item
